Form 4 holding
10%+ Owner
Invivyd, Inc.
- Security class
- Common Stock
- Shares / value
- 21,687,906
- Estimated value
- $85,667,229
- Report date
- 19 Jan 2024
- Price
- $3.95
- Ownership
- Direct
Adimab, LLC
Insider Reports History
- Location
- Lebanon, NH
- Signature
- By: /s/ Philip Chase, Chief Executive Officer
- Transaction view
- Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Holdings reported by Adimab, LLC:
Insider Reports Filed by Adimab, LLC
4
IVVD
Invivyd, Inc.
- Report period
- 19 Jan 2024
- Transactions
- 1
- Transaction value
- -$19,750,000
- Filing time
- 22 Jan 2024, 16:18
- Role
- 10%+ Owner
- Next action
- Open filing details
4
IVVD
Adagio Therapeutics, Inc.
- Report period
- 03 Mar 2022
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 01 Apr 2022, 16:08
- Role
- Other*, 10%+ Owner
- Next action
- Open filing details
4
IVVD
Adagio Therapeutics, Inc.
- Report period
- 10 Aug 2021
- Transactions
- 4
- Transaction value
- $0
- Filing time
- 12 Aug 2021, 21:22
- Role
- 10%+ Owner
- Next action
- Open filing details
3
IVVD
Adagio Therapeutics, Inc.
- Report period
- 05 Aug 2021
- Transactions
- 0
- Transaction value
- $0
- Filing time
- 05 Aug 2021, 21:14
- Role
- 10%+ Owner
- Next action
- Open filing details